WPD Pharmaceuticals Company Top Insiders
WPD Pharmaceuticals employs about 19 people. The company is managed by 6 executives with a total tenure of roughly 45 years, averaging almost 7.0 years of service per executive, having 3.17 employees per reported executive. Examination of WPD Pharmaceuticals' management performance can provide insight into the company performance.
| CMA CPA Insider Chief Officer |
| Mariusz Olejniczak Insider Chief Officer |
WPD |
WPD Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (1.2889) % which means that it has lost $1.2889 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (21.7977) %, meaning that it generated substantial loss on money invested by shareholders. WPD Pharmaceuticals' management efficiency ratios could be used to measure how well WPD Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.WPD Pharmaceuticals retains a total of 113.44 Million outstanding shares. WPD Pharmaceuticals owns noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as WPD Pharmaceuticals in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of WPD Pharmaceuticals, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
WPD Pharmaceuticals Workforce Comparison
WPD Pharmaceuticals is rated first in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 118. WPD Pharmaceuticals retains roughly 19.0 in number of employees claiming about 16% of stocks in Biotechnology industry.
WPD Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. WPD Pharmaceuticals Price Series Summation is a cross summation of WPD Pharmaceuticals price series and its benchmark/peer.
WPD Pharmaceuticals Notable Stakeholders
A WPD Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as WPD Pharmaceuticals often face trade-offs trying to please all of them. WPD Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting WPD Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| CMA CPA | Chief Officer | Profile | |
| Mariusz Olejniczak | Chief Officer | Profile | |
| Beata Eng | Chief Officer | Profile | |
| Waldemar Priebe | Founder Board | Profile | |
| Katarzyna Suchoszek | Chief Officer | Profile | |
| Marek MD | Chief Officer | Profile |
About WPD Pharmaceuticals Management Performance
The success or failure of an entity such as WPD Pharmaceuticals often depends on how effective the management is. WPD Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of WPD management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the WPD management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
WPD Pharmaceuticals Inc. engages in the research and development of medicinal products in the fields of oncology and infectious diseases. WPD Pharmaceuticals Inc. is headquartered in Vancouver, Canada. Wpd Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 19 people.
WPD Pharmaceuticals Workforce Analysis
Traditionally, organizations such as WPD Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare WPD Pharmaceuticals within its industry.WPD Pharmaceuticals Manpower Efficiency
Return on WPD Pharmaceuticals Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 395.9K | |
| Net Loss Per Executive | 1.3M |
Complementary Tools for WPD Pink Sheet analysis
When running WPD Pharmaceuticals' price analysis, check to measure WPD Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy WPD Pharmaceuticals is operating at the current time. Most of WPD Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of WPD Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move WPD Pharmaceuticals' price. Additionally, you may evaluate how the addition of WPD Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |